News & Updates
Filter by Specialty:

PVR predicts death in patients with bronchiectasis-associated pulmonary hypertension
Pulmonary vascular resistance (PVR) may be used to distinguish severe (PVR >4 Wood Units) from nonsevere pulmonary hypertension (PVR ≤4 Wood Units) among patients with bronchiectasis-associated pulmonary hypertension (BAPH) and identify those who are at higher risk of mortality, a study suggests.
PVR predicts death in patients with bronchiectasis-associated pulmonary hypertension
04 Sep 2024
Add-on acalabrutinib prolongs PFS in older patients with untreated MCL
In older patients with untreated mantle cell lymphoma (MCL), the addition of the Bruton tyrosine kinase (BTK) inhibitor acalabrutinib to bendamustine and rituximab (ABR) conferred a statistically significant and clinically meaningful improvement in progression-free survival (PFS) with a favourable trend for overall survival (OS), findings from the phase III ECHO trial have shown.
Add-on acalabrutinib prolongs PFS in older patients with untreated MCL
04 Sep 2024
Yoga on par with physical conditioning in reducing UI in women
A pelvic yoga program for 12 weeks does not seem to be better than a general muscle stretching and strengthening program in lowering urinary incontinence (UI) in midlife and older women suffering from daily UI, reports a study.